APA (7th ed.) Citation

El Sahly, H. M., Patel, S. M., Atmar, R. L., Lanford, T. A., Dube, T., Thompson, D., . . . Keitel, W. A. (2010). Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria Is Not Endemic. Clinical and Vaccine Immunology, 17(10), 1552-1559. https://doi.org/10.1128/CVI.00082-10

Chicago Style (17th ed.) Citation

El Sahly, H. M., S. M. Patel, R. L. Atmar, T. A. Lanford, T. Dube, D. Thompson, B. K. L. Sim, C. Long, and W. A. Keitel. "Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria Is Not Endemic." Clinical and Vaccine Immunology 17, no. 10 (2010): 1552-1559. https://doi.org/10.1128/CVI.00082-10.

MLA (9th ed.) Citation

El Sahly, H. M., et al. "Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria Is Not Endemic." Clinical and Vaccine Immunology, vol. 17, no. 10, 2010, pp. 1552-1559, https://doi.org/10.1128/CVI.00082-10.